Literature DB >> 3112019

[Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].

H M Just, M Termöhlen, M Pinkawa, F D Daschner.   

Abstract

The in vitro influence of a pseudomonas immunoglobulin in active and inactivated serum on the bactericidal activity and phagocytosis of human polymorphonuclear leukocytes was evaluated against Pseudomonas aeruginosa. No lysis of the bacteria could be found in either serum, however, the bactericidal activity of the leukocytes was significantly enhanced in active serum (p less than or equal to 0.05), whereas no effect was measurable in inactivated serum. Phagocytosis could be increased in concentrations of 10% immunoglobulin, (equivalent to 5 mg IgG/ml); however, a concentration of 15% showed a lower phagocytosis index which was comparable to that in the 5% preparation. This immunoglobulin proved to be able to support the bacterial phagocytosis and killing of P. aeruginosa by human polymorphonuclear leukocytes in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112019     DOI: 10.1007/bf01644191

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Factors affecting mortality of gram-negative rod bacteremia.

Authors:  R E Bryant; A F Hood; C E Hood; M G Koenig
Journal:  Arch Intern Med       Date:  1971-01

Review 2.  Intravenous immunoglobulins: pharmacological aspects and therapeutic use.

Authors:  A Hässig
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

3.  Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.

Authors:  R van Furth; P C Leijh; F Klein
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

4.  [Immunoglobulins in bacterial and viral meningitis. Results of a controlled randomized clinical study of intravenous and intrathecal application].

Authors:  I S Neu; R B Pelka
Journal:  Fortschr Med       Date:  1982-05-06

5.  Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.

Authors:  M S Collins; R E Roby
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

6.  A comparison of immunologic profiles and their influence on bacteremia in surgical patients with a high risk of infection.

Authors:  J W Alexander; J D Stinnett; C K Ogle; J D Ogle; M J Morris
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

7.  Neutralization of bacterial lipopolysaccharides by human plasma.

Authors:  H S Warren; T J Novitsky; P A Ketchum; P F Roslansky; S Kania; G R Siber
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

8.  [Effect of adjuvant immunoglobulin therapy on infections in patients in an surgical intensive care unit. Results of a randomized controlled study].

Authors:  H M Just; M Metzger; W Vogel; R B Pelka
Journal:  Klin Wochenschr       Date:  1986-03-17

9.  Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients.

Authors:  W Marget; P J Mar; L Jaspers; K Possinger; H Haslberger
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

10.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.